Teleflex Inc. (TFX) Receives Average Recommendation of “Buy” from Brokerages
Shares of Teleflex Inc. (NYSE:TFX) have been assigned an average rating of “Buy” from the eleven brokerages that are covering the stock. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $170.71.
TFX has been the subject of several research reports. Zacks Investment Research lowered shares of Teleflex from a “hold” rating to a “sell” rating in a research report on Tuesday, November 1st. Stephens lowered shares of Teleflex from an “overweight” rating to an “equal weight” rating in a research report on Friday, October 28th. Leerink Swann upped their price target on shares of Teleflex from $183.00 to $190.00 and gave the company a “market perform” rating in a research report on Friday, July 29th. Jefferies Group upped their price target on shares of Teleflex from $157.00 to $185.00 and gave the company a “hold” rating in a research report on Friday, July 29th. Finally, Barclays PLC upped their price target on shares of Teleflex from $183.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday, July 29th.
A number of hedge funds have recently added to or reduced their stakes in TFX. Tower Research Capital LLC TRC acquired a new stake in Teleflex during the second quarter worth $118,000. Huntington National Bank raised its stake in Teleflex by 6.5% in the second quarter. Huntington National Bank now owns 820 shares of the medical technology company’s stock worth $145,000 after buying an additional 50 shares during the last quarter. Checchi Capital Advisers LLC raised its stake in Teleflex by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 837 shares of the medical technology company’s stock worth $148,000 after buying an additional 7 shares during the last quarter. Welch & Forbes LLC acquired a new stake in Teleflex during the second quarter worth $204,000. Finally, Broderick Brian C acquired a new stake in Teleflex during the second quarter worth $207,000. Institutional investors and hedge funds own 93.89% of the company’s stock.
Shares of Teleflex (NYSE:TFX) traded up 1.25% during midday trading on Friday, reaching $150.23. 254,634 shares of the company’s stock traded hands. The firm has a market capitalization of $6.62 billion, a PE ratio of 25.95 and a beta of 0.88. Teleflex has a one year low of $125.28 and a one year high of $188.79. The stock’s 50-day moving average price is $156.60 and its 200 day moving average price is $169.50.
Teleflex (NYSE:TFX) last posted its earnings results on Thursday, October 27th. The medical technology company reported $1.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.78 by $0.02. The business had revenue of $455.60 million for the quarter, compared to analysts’ expectations of $461.80 million. Teleflex had a net margin of 15.09% and a return on equity of 15.66%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.60 EPS. On average, equities research analysts expect that Teleflex will post $7.30 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Shareholders of record on Tuesday, November 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Thursday, November 10th. This represents a $1.36 dividend on an annualized basis and a yield of 0.92%. Teleflex’s payout ratio is 23.49%.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
Receive News & Stock Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related stocks with our FREE daily email newsletter.